Labcorp Holdings Pre-Tax Profit Margin 2012-2026 | LH
Current and historical pre-tax profit margin for Labcorp Holdings (LH) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Labcorp Holdings pre-tax profit margin for the three months ending June 30, 2026 was .
| Labcorp Holdings Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-06-30 | $14.35B | $1.23B | 8.60% |
| 2026-03-31 | $14.15B | $1.15B | 8.15% |
| 2025-12-31 | $13.95B | $1.11B | 7.94% |
| 2025-09-30 | $13.77B | $1.10B | 8.00% |
| 2025-06-30 | $13.48B | $0.98B | 7.23% |
| 2025-03-31 | $13.18B | $0.94B | 7.12% |
| 2024-12-31 | $13.01B | $0.96B | 7.38% |
| 2024-09-30 | $12.71B | $0.63B | 4.95% |
| 2024-06-30 | $12.49B | $0.66B | 5.26% |
| 2024-03-31 | $12.30B | $0.59B | 4.83% |
| 2023-12-31 | $12.16B | $0.57B | 4.68% |
| 2023-09-30 | $11.30B | $0.64B | 5.64% |
| 2023-06-30 | $11.11B | $0.72B | 6.43% |
| 2023-03-31 | $11.00B | $0.87B | 7.91% |
| 2022-12-31 | $11.87B | $1.24B | 10.43% |
| 2022-09-30 | $10.76B | $1.76B | 16.38% |
| 2022-06-30 | $11.96B | $2.22B | 18.52% |
| 2022-03-31 | $12.88B | $2.51B | 19.46% |
| 2021-12-31 | $13.14B | $2.89B | 21.98% |
| 2021-09-30 | $16.56B | $3.68B | 22.25% |
| 2021-06-30 | $16.39B | $3.86B | 23.57% |
| 2021-03-31 | $15.32B | $3.51B | 22.91% |
| 2020-12-31 | $13.98B | $2.22B | 15.87% |
| 2020-09-30 | $12.44B | $1.27B | 10.20% |
| 2020-06-30 | $11.48B | $0.61B | 5.31% |
| 2020-03-31 | $11.59B | $0.58B | 5.02% |
| 2019-12-31 | $11.56B | $1.11B | 9.56% |
| 2019-09-30 | $11.39B | $1.03B | 9.02% |
| 2019-06-30 | $11.29B | $1.24B | 10.98% |
| 2019-03-31 | $11.28B | $1.28B | 11.38% |
| 2018-12-31 | $11.33B | $1.27B | 11.21% |
| 2018-09-30 | $11.29B | $1.32B | 11.70% |
| 2018-06-30 | $11.08B | $1.09B | 9.82% |
| 2018-03-31 | $10.74B | $1.05B | 9.81% |
| 2017-12-31 | $10.31B | $1.08B | 10.45% |
| 2017-09-30 | $9.90B | $1.06B | 10.66% |
| 2017-06-30 | $9.70B | $1.05B | 10.85% |
| 2017-03-31 | $9.60B | $1.09B | 11.30% |
| 2016-12-31 | $9.55B | $1.07B | 11.24% |
| 2016-09-30 | $9.52B | $1.01B | 10.56% |
| 2016-06-30 | $9.42B | $0.99B | 10.56% |
| 2016-03-31 | $9.26B | $0.95B | 10.24% |
| 2015-12-31 | $8.68B | $0.73B | 8.38% |
| 2015-09-30 | $7.89B | $0.73B | 9.28% |
| 2015-06-30 | $7.13B | $0.70B | 9.81% |
| 2015-03-31 | $6.37B | $0.67B | 10.45% |
| 2014-12-31 | $6.01B | $0.82B | 13.66% |
| 2014-09-30 | $5.94B | $0.83B | 14.05% |
| 2014-06-30 | $5.85B | $0.85B | 14.45% |
| 2014-03-31 | $5.80B | $0.86B | 14.87% |
| 2013-12-31 | $5.81B | $0.92B | 15.75% |
| 2013-09-30 | $5.78B | $0.91B | 15.81% |
| 2013-06-30 | $5.73B | $0.91B | 15.87% |
| 2013-03-31 | $5.69B | $0.92B | 16.10% |
| 2012-12-31 | $5.67B | $0.95B | 16.67% |
| 2012-09-30 | $5.63B | $0.98B | 17.37% |
| 2012-06-30 | $5.62B | $0.97B | 17.29% |
| 2012-03-31 | $5.60B | $0.92B | 16.47% |
| 2011-12-31 | $5.54B | $0.87B | 15.63% |
| 2011-09-30 | $5.47B | $0.86B | 15.66% |
| 2011-06-30 | $5.34B | $0.85B | 15.98% |
| 2011-03-31 | $5.18B | $0.91B | 17.52% |
| 2010-12-31 | $5.00B | $0.92B | 18.31% |
| 2010-09-30 | $4.87B | $0.90B | 18.53% |
| 2010-06-30 | $4.78B | $0.91B | 19.01% |
| 2010-03-31 | $4.73B | $0.88B | 18.61% |
| 2009-12-31 | $4.70B | $0.88B | 18.83% |
| 2009-09-30 | $4.65B | $0.87B | 18.71% |
| 2009-06-30 | $4.60B | $0.84B | 18.20% |
| 2009-03-31 | $4.56B | $0.79B | 17.24% |
| 2008-12-31 | $4.51B | $0.79B | 17.45% |
| 2008-09-30 | $4.39B | $0.78B | 17.85% |
| 2008-06-30 | $4.28B | $0.78B | 18.26% |
| 2008-03-31 | $4.17B | $0.82B | 19.63% |
| 2007-12-31 | $4.07B | $0.80B | 19.71% |
| 2007-09-30 | $3.96B | $0.79B | 19.81% |
| 2007-06-30 | $3.85B | $0.78B | 20.28% |
| 2007-03-31 | $3.71B | $0.76B | 20.42% |
| 2006-12-31 | $3.59B | $0.72B | 20.07% |
| 2006-09-30 | $3.52B | $0.70B | 19.80% |
| 2006-06-30 | $3.46B | $0.67B | 19.38% |
| 2006-03-31 | $3.41B | $0.65B | 19.08% |
| 2005-12-31 | $3.33B | $0.64B | 19.27% |
| 2005-09-30 | $3.27B | $0.64B | 19.56% |
| 2005-06-30 | $3.20B | $0.64B | 19.99% |
| 2005-03-31 | $3.13B | $0.63B | 20.15% |
| 2004-12-31 | $3.09B | $0.62B | 19.96% |
| 2004-09-30 | $3.05B | $0.60B | 19.80% |
| 2004-06-30 | $3.02B | $0.58B | 19.34% |
| 2004-03-31 | $2.98B | $0.56B | 18.89% |
| 2003-12-31 | $2.94B | $0.54B | 18.37% |
| 2003-09-30 | $2.86B | $0.50B | 17.46% |
| 2003-06-30 | $2.76B | $0.46B | 16.66% |
| 2003-03-31 | $2.63B | $0.45B | 16.93% |
| 2002-12-31 | $2.51B | $0.43B | 17.23% |
| 2002-09-30 | $2.42B | $0.41B | 16.94% |
| 2002-06-30 | $2.33B | $0.40B | 17.02% |
| 2002-03-31 | $2.27B | $0.36B | 15.89% |
| 2001-12-31 | $2.20B | $0.33B | 14.86% |
| 2001-09-30 | $2.12B | $0.30B | 14.00% |
| 2001-06-30 | $2.05B | $0.27B | 13.37% |
| 2001-03-31 | $1.98B | $0.24B | 12.12% |
| 2000-12-31 | $1.92B | $0.21B | 10.89% |
| 2000-09-30 | $1.86B | $0.19B | 10.40% |
| 2000-06-30 | $1.80B | $0.16B | 8.90% |
| 2000-03-31 | $1.75B | $0.13B | 7.51% |
| 1999-12-31 | $1.70B | $0.11B | 6.24% |
| 1999-09-30 | $1.69B | $0.10B | 5.82% |
| 1999-06-30 | $1.65B | $0.09B | 5.56% |
| 1999-03-31 | $1.61B | $0.09B | 5.28% |
| 1998-12-31 | $1.57B | $0.08B | 5.18% |
| 1998-09-30 | $1.52B | $-0.13B | -8.23% |
| 1998-06-30 | $1.50B | $-0.13B | -8.95% |
| 1998-03-31 | $1.50B | $-0.15B | -9.93% |
| 1997-12-31 | $1.52B | $-0.16B | -10.66% |
| 1997-09-30 | $1.55B | $0.03B | 2.00% |
| 1997-06-30 | $1.58B | $-0.17B | -10.47% |
| 1997-03-31 | $1.60B | $-0.20B | -12.22% |
| 1996-12-31 | $1.61B | $-0.19B | -11.75% |
| 1996-09-30 | $1.62B | $-0.19B | -11.73% |
| 1996-06-30 | $1.64B | $0.02B | 1.16% |
| 1996-03-31 | $1.59B | $-0.01B | -0.50% |
| 1995-12-31 | $1.43B | $0.00B | 0.21% |
| 1995-09-30 | $1.26B | $0.24B | 18.75% |
| 1995-06-30 | $1.10B | $0.21B | 19.45% |
| 1995-03-31 | $0.93B | $0.46B | 49.79% |
| 1994-12-31 | $0.87B | $0.46B | 52.12% |
| 1994-09-30 | $0.81B | $0.23B | 29.00% |
| 1994-06-30 | $0.75B | $0.30B | 39.58% |
| 1994-03-31 | $0.75B | $0.15B | 19.97% |
| 1993-12-31 | $0.76B | $0.19B | 25.10% |
| 1993-09-30 | $0.77B | $0.09B | 11.53% |
| 1993-06-30 | $0.76B | $0.07B | 9.59% |
| 1993-03-31 | $0.75B | $0.07B | 9.26% |
| 1992-12-31 | $0.72B | $0.06B | 8.60% |
| 1992-09-30 | $0.70B | $0.19B | 27.77% |
| 1992-06-30 | $0.67B | $0.19B | 27.97% |
| 1992-03-31 | $0.64B | $0.18B | 28.06% |
| 1991-12-31 | $0.60B | $0.17B | 28.15% |
| 1991-09-30 | $0.58B | $0.16B | 27.95% |
| 1991-06-30 | $0.55B | $0.15B | 27.55% |
| 1991-03-31 | $0.52B | $0.14B | 27.45% |
| 1990-12-31 | $0.50B | $0.14B | 27.35% |
| 1990-06-30 | $0.35B | $0.10B | 28.08% |
| 1990-03-31 | $0.32B | $0.09B | 28.16% |
| 1989-06-30 | $0.27B | $0.08B | 27.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $26.274B | $13.952B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.177B | 25.78 |
| CVS Health (CVS) | United States | $120.850B | 12.05 |
| HCA Healthcare (HCA) | United States | $91.758B | 14.27 |
| Elevance Health (ELV) | United States | $90.552B | 14.21 |
| Cencora (COR) | United States | $61.693B | 18.85 |
| Natera (NTRA) | United States | $50.563B | 0.00 |
| Viatris (VTRS) | United States | $19.124B | 6.61 |
| Medpace Holdings (MEDP) | United States | $17.319B | 36.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.369B | 0.00 |
| DiDi Global (DIDIY) | China | $16.046B | 176.00 |
| Revvity (RVTY) | United States | $15.643B | 26.20 |
| Solventum (SOLV) | United States | $15.330B | 12.69 |
| ICON (ICLR) | Ireland | $13.204B | 17.94 |
| Charles River Laboratories (CRL) | United States | $13.027B | 27.56 |
| BrightSpring Health Services (BTSG) | United States | $11.642B | 40.03 |
| Avantor (AVTR) | United States | $10.443B | 18.83 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.054B | 79.17 |
| HealthEquity (HQY) | United States | $7.983B | 26.01 |
| Sonic Healthcare (SKHHY) | Australia | $6.771B | 0.00 |
| PACS (PACS) | United States | $6.662B | 22.39 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.327B | 0.00 |
| MiniMed (MMED) | United States | $6.193B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.157B | 23.28 |
| Sotera Health (SHC) | United States | $5.416B | 22.33 |
| Concentras Parent (CON) | United States | $4.542B | 22.40 |
| Organon (OGN) | United States | $3.587B | 4.55 |
| GeneDx Holdings (WGS) | United States | $2.822B | 262.89 |
| CareDx (CDNA) | United States | $2.723B | 309.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.169B | 12.71 |
| Alignment Healthcare (ALHC) | United States | $2.151B | 54.58 |
| Establishment Labs Holdings (ESTA) | United States | $2.130B | 0.00 |
| Progyny (PGNY) | United States | $2.130B | 30.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.912B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.907B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.787B | 68.25 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.573B | 0.00 |
| Agilon Health (AGL) | United States | $1.547B | 0.00 |
| Ardent Health (ARDT) | United States | $1.508B | 8.62 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Nutex Health (NUTX) | United States | $1.475B | 8.45 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.204B | 245.88 |
| GoodRx Holdings (GDRX) | United States | $1.196B | 23.27 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| CryoPort (CYRX) | United States | $0.826B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.688B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.472B | 9.77 |
| Strata Critical Medical (SRTA) | United States | $0.468B | 0.00 |
| Forward Industries (FWDI) | United States | $0.449B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.382B | 5.55 |
| Shoulder Innovations (SI) | United States | $0.374B | 0.00 |
| Biodesix (BDSX) | United States | $0.292B | 0.00 |
| Embecta (EMBC) | United States | $0.288B | 2.50 |
| So-Young (SY) | China | $0.276B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.098B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.068B | 8.06 |
| Tevogen (TVGN) | United States | $0.050B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.008B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |